Biomarkers of Chinese advanced cancer patients based on real-world data: Actionable genomic alterations and tumor mutational burden.

被引：0
|
作者：
Wang, HaiTao
Wang, Huina
Guo, Rongyun
Li, Mingwei
Zhang, Yanrui
Lou, Feng
Cao, Shanbo
机构：
[1] Tianjin Med Univ, Tianjin, Peoples R China
[2] Acornmed Biotechnol Co Ltd, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14280
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14280
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world insights into patients with advanced NSCLC and MET alterations
    Bittoni, Marisa
    Yang, James Chih-Hsin
    Shih, Jin-Yuan
    Peled, Nir
    Smit, Egbert F.
    Camidge, D. Ross
    Arasada, Rajeswara Rao
    Oksen, Dina
    Boutmy, Emmanuelle
    Stroh, Christopher
    Johne, Andreas
    Carbone, David P.
    Paik, Paul K.
    LUNG CANCER, 2021, 159 : 96 - 106
  • [22] Clinical and utilization outcomes associated with tumor mutational burden in a real-world pan-tumor population
    Gautam, Santosh
    Kachroo, Sumesh
    DeClue, Richard W.
    Fisher, Maxine D.
    Basu, Anirban
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (10) : 857 - 868
  • [23] Real-World Impact of Plasma Cell-Free DNA Next-Generation Sequencing to Detect Actionable Genomic Alterations in Advanced NSCLC
    Ahn, B.
    Lee, S.
    Olsen, S.
    Mehta, D.
    Lim, S. M.
    Hong, M. H.
    Kim, H. R.
    Cho, B. C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S691 - S691
  • [24] Liquid biopsy-based comprehensive genomic profiling to reveal mutational landscape in real-world patients with gastrointestinal cancer.
    Tang, Haoran
    Zhang, Xiaogang
    Xie, Feng
    Zhang, Yue
    Jia, Shidong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 735 - 735
  • [25] Real-world outcomes of an automated physician support system for analysis of actionable co-alterations and molecular biomarker patterns in advanced breast cancer patients
    Hempel, L.
    Ebner, F.
    de Oliveira, Veloso J.
    Hempel, D.
    Robert, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 6 - 6
  • [26] Genomic Landscape of ctDNA and Real-World Outcomes in Advanced Endometrial Cancer
    Soberanis Pina, Pamela
    Clemens, Keelia
    Bubie, Adrian
    Grant, Brooke
    Haynes, Ginger
    Zhang, Nicole
    Drusbosky, Leylah
    Lheureux, Stephanie
    CLINICAL CANCER RESEARCH, 2024, 30 (24) : 5657 - 5665
  • [27] Landscape of Biomarkers and Actionable Gene Alterations in Adenocarcinoma of GEJ and Stomach-A Real World Data Analysis
    Hempel, Louisa
    de Oliveira, Julia Veloso
    Gaumann, Andreas
    Milani, Valeria
    Schweneker, Katrin
    Schenck, Kristina
    Fleischmann, Bastian
    Philipp, Patrick
    Mederle, Stefanie
    Garg, Arun
    Piehler, Armin
    Gandorfer, Beate
    Schick, Cordula
    Kleespies, Axel
    Sellmann, Ludger
    Bartels, Marius
    Goetze, Thorsten Oliver
    Stein, Alexander
    Goekkurt, Eray
    Pfitzner, Lucia
    Robert, Sebastian
    Hempel, Dirk
    CANCERS, 2021, 13 (17)
  • [28] Real-world concordance between tumor mutational burden (TMB) from blood (circulating tumor DNA) and tissue in lung cancer.
    Park, Inae
    Hwang, Jin Young
    Bae, William
    Lee, Grace
    Kim, Leeseul
    Choi, Yoonhee
    Jung, Hojung
    Chae, Young Kwang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Actionable genomic landscapes from a real-world cohort of localized urothelial carcinoma patients.
    Gerald, Thomas
    Margulis, Vitaly
    Meng, Xiaosong
    Cole, Suzanne
    Qin, Qian
    Call, Greg
    Mauer, Elizabeth
    Lotan, Yair
    Woldu, Solomon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [30] Real-world insights into patients (pts) with advanced NSCLC and MET alterations
    Bittoni, M.
    Yang, J. C-H.
    Shih, J-Y.
    Peled, N.
    Smit, E.
    Camidge, R.
    Carbone, D.
    Oksen, D.
    Boutmy, E.
    Johne, A.
    Paik, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S1398 - S1399
12345